Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed Aug 13, 2021. Long positions only.
- Positions
- 136
- No 13F data for Q4 2020
- Portfolio value
- $7.52B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MORFMorphic Holding, Inc. | COM | 938,140 | $59.4M | 0.8% | – | – | History |
| QTNTQuotient Ltd | SHS | 16,200,818 | $59.6M | 0.8% | – | – | History |
| NARIInari Medical, Inc. | Stock | 565,113 | $60.5M | 0.8% | – | – | History |
| KDMNKadmon Holdings, Inc. | COM | 15,711,334 | $61.1M | 0.8% | – | – | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 987,287 | $61.7M | 0.8% | – | – | History |
| LONALeonaBio, Inc. | COM | 3,425,916 | $63.0M | 0.8% | – | – | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 4,643,095 | $63.7M | 0.8% | – | – | History |
| MGNXMacrogenics Inc | COM | 2,148,060 | $68.4M | 0.9% | – | – | History |
| CHRSCoherus Oncology, Inc. | COM | 4,697,612 | $68.6M | 0.9% | – | – | History |
| RLAYRelay Therapeutics, Inc. | COM | 2,018,097 | $69.8M | 0.9% | – | – | History |
| SLDBSolid Biosciences Inc. | COM | 13,412,552 | $74.2M | 1.0% | – | – | History |
| KRONKronos Bio, Inc. | COM | 2,780,097 | $79.7M | 1.1% | – | – | History |
| TVTXTravere Therapeutics, Inc. | COM | 3,298,419 | $82.4M | 1.1% | – | – | History |
| ALBOAlbireo Pharma, Inc. | COM | 2,360,139 | $83.2M | 1.1% | – | – | History |
| NBIXNeurocrine Biosciences Inc | Stock | 941,832 | $91.6M | 1.2% | – | – | History |
| MGTXMeiraGTx Holdings plc | COM | 6,933,277 | $93.4M | 1.2% | – | – | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 8,703,879 | $103.4M | 1.4% | – | – | History |
| NVRONevro Corp | COM | 812,154 | $113.3M | 1.5% | – | – | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 3,158,566 | $116.8M | 1.6% | – | – | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 2,867,771 | $127.2M | 1.7% | – | – | History |
| OMOutset Medical, Inc. | COM | 2,387,535 | $129.9M | 1.7% | – | – | History |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $135.3M | 1.8% | – | – | – |
| ZYMEZymeworks Inc. | COM | 4,330,868 | $136.8M | 1.8% | – | – | History |
| LABPLandos Biopharma, Inc. | COM | 14,869,915 | $141.0M | 1.9% | – | – | History |
| VBIVVBI Vaccines Inc/BC | COM NEW | 55,042,465 | $171.2M | 2.3% | – | – | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 3,109,224 | $184.7M | 2.5% | – | – | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 2,050,002 | $188.7M | 2.5% | – | – | History |
| Collegium Pharmaceutical, Inc19459JAA2 | NOTE 2.625% 2/1 | – | $189.6M | 2.5% | – | – | – |
| NVTAInvitae Corp | COM | 5,360,673 | $204.8M | 2.7% | – | – | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 5,058,642 | $206.1M | 2.7% | – | – | History |
| FOLDAmicus Therapeutics, Inc. | COM | 22,861,329 | $225.9M | 3.0% | – | – | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 8,651,785 | $273.9M | 3.6% | – | – | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 4,849,912 | $356.8M | 4.7% | – | – | History |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $474.8M | 6.3% | – | – | – |
| BBIOBridgeBio Pharma, Inc. | COM | 7,756,928 | $477.8M | 6.4% | – | – | History |
| MRTXMirati Therapeutics, Inc. | COM | 3,474,505 | $595.2M | 7.9% | – | – | History |
Options (2)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.